Nyhet -
ETVAX® ”the lead candidate” på CISTM14
”Etvax is the lead candidate in the field of ETEC”. Så sa Richard Walker under programpunkten ”Advances in ETEC and Shigella prevention throught vaccination” på International Society of Travel Medicin konferens, CISTM14, förra veckan.
Richard Walker från den amerikanska ideella hälsoorganisation Path Vaccine Solutions presenterade även vaccinets genomgångna studier och projektets utveckling.
CISTM arrangeras vartannat år och lockar resemedicinska experter och opinionsledare världen över. Omkring 2000 deltagare från över 50 länder var på plats under årets konferens som hölls i Quebec, Kanada
In english:
ETVAX® was presented as the lead candidate at CISTM14
The International Society of Travel Medicine (ISTM) holds its leading worldwide scientific congress biennially. Approximately 2,000 delegates from over 50 countries is attending.
CISTM14 – 14th conference of the International Society of Travel Medicine has just been organized in Québec City, Canada. During the conference an up-to-date and broad-ranging program was presented by the key opinion leaders in the field. People from all over the world met and discussed travel related diseases.
Our ETEC vaccine Etvax® was of cause on the agenda. During a satellite symposium Richard Walker, from the American non-profit organization PATH Vaccine Solutions, described our vaccine project as the lead project when the “Advances in ETEC and Shigella prevention through vaccination” was presented.
